Halia Therapeutics CEO David Bearss, PhD, Mark Ott, MD, dean of the BYU School of Medicine, and Bob Carter, MD, PhD, CEO of University of Utah Health, discussed how the healthcare system will deal with the upcoming “silver tsunami.”

Recommended For You

Fireside Chat: National Security Commission on Emerging Biotechnology

The National Security Commission on Emerging Biotechnology (
The Miracle of Modern Medicine

As the former director of the Center for Biologics Evaluatio
Fireside Chat: Trade Regulations Affecting Life Sciences

Michelle Holyoak and Jacey Skinner discussed several topics

FDA Town Hall with Dr. Michelle Tarver

Dr. Michelle Tarver, Director of the Center for Devices and

AI and Structural Impacts in Healthcare

Carter Dredge, PhD, Bus.D, executive director, Intermountain